Cambridge's Moderna asking U.S., European regulators to OK its virus shots
Moderna is just behind Pfizer and its German partner BioNTech in seeking to begin vaccinations in the U.S. in December. |!| Cambridge Boston
Moderna is just behind Pfizer and its German partner BioNTech in seeking to begin vaccinations in the U.S. in December. |!| Cambridge Boston